Skip to content

FEBELFARMA

Active
Private limited companyfounded 2002active for 23 yearsEigenlostraat 1, 9100 Sint-Niklaas, BelgiumKBO/BCE: BE 0479.127.936
Summary

FEBELFARMA has been active since 2002 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.0m and a net result of €45,753. Equity is growing by about 5% per year across the filed financial years. Its solvency ranks better than 95% of 3,821 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

History

On 23 December 2002, FEBELFARMA was incorporated.1 Turnover went from €31,531 in 2018 to €59,365 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
31-08
NBB filing Annual accounts filed
financial year 2025 · full format · 31 days late
16-07
Gazette deed Resignation: BV ALEXO (bestuurder)
Permanent representatives: Olivier Delaere, Koen Straetmans and 2 others · Appointments: BV KST Pharma (director) and BV ARISTO (voorzitter van het bestuursorgaan)11 facts ▸
  • General meeting, 18-05-2026
  • Director resignation, BV ALEXO ((gedelegeerd) bestuurder)
  • Permanent representative, Olivier Delaere
  • Director appointment, BV KST Pharma (director)
  • Permanent representative, Koen Straetmans
  • Board meeting, 18-05-2026
  • Director appointment, BV ARISTO (voorzitter van het bestuursorgaan)
  • Permanent representative, Frank Coene
  • Director appointment, BV KST Pharma (managing director)
  • Other provision, “alle zaken die verband houden met de uitoefening van zijn mandaat”, elected domicile (deed in Dutch)
  • Permanent representative, Eric Van Nueten
2025
31-12
Financial Equity above €2mequity €2.0m ▲2.3%
4 profitable years in a row build equity to €2.0m.
03-11
Gazette deed Reappointment: Moore Audit BV (statutory auditor)
Permanent representatives: Koen Van Eupen and Pieterjan Boeykens4 facts ▸
  • General meeting, 16-04-2025
  • Auditor reappointment, Moore Audit BV (statutory auditor)
  • Permanent representative, Koen Van Eupen
  • Permanent representative, Pieterjan Boeykens
28-08
NBB filing Annual accounts filed
financial year 2024 · full format · 28 days late
2024
31-12
Financial Highest result from 2018 to 2025net €608,557 ▲2,409%
Operating result €579,073, net result €608,557, both a record.
30-10
Gazette deed Appointments: Alexo, Aristo and Van Nueten Eric Flor André
Permanent representatives: Olivier Delaere and Frank Coene · Reappointments: Alexo (managing director) and Aristo (chair of the board)9 facts ▸
  • Board meeting, 12-09-2024
  • Director appointment, Alexo (director (not named in the articles))
  • Director appointment, Aristo (director (not named in the articles))
  • Director appointment, Van Nueten Eric Flor André (director (not named in the articles))
  • Permanent representative, Olivier Delaere
  • Permanent representative, Frank Coene
  • Director reappointment, Alexo (managing director)
  • Director reappointment, Aristo (chair of the board)
  • Director in office, Eveline Van den Abeele (director)
30-08
NBB filing Annual accounts filed
financial year 2023 · full format · 30 days late
2023
31-08
NBB filing Annual accounts filed
financial year 2022 · full format · 31 days late
2022
31-12
Financial Back to profitnet €40,155
Net result €40,155 after one loss-making year.
27-06
NBB filing Annual accounts filed
financial year 2021 · full format
2021
31-12
Financial Weakest financial yearnet -€137,077
Net result drops to -€137,077, the lowest in the series; recovery starts the following year.
Show earlier events
14-06
NBB filing Annual accounts filed
financial year 2020 · full format
2020
31-12
Financial Liquidity more than doubledcurrent ratio 481.40
Current ratio from 206.43 to 481.40; short-term debt falls from €8,789 to €3,388.
22-06
NBB filing Annual accounts filed
financial year 2019 · full format
2019
31-12
Financial Liquidity more than 11 timescurrent ratio 206.43
Current ratio from 17.72 to 206.43; short-term debt falls from €104,404 to €8,789.
14-06
NBB filing Annual accounts filed
financial year 2018 · full format
2018
13-06
NBB filing Annual accounts filed
financial year 2017 · full format
2017
24-05
NBB filing Annual accounts filed
financial year 2016 · full format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 23 annual accounts filed, the latest 10 are here; all 23 are under Financials.
3 of 13 deeds read
About the unread acts

Of the 13 Belgian Official Gazette deeds we know for this company, 3 have been read. The other 10 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.